Statin Use Survey Among the First to Highlight Importance of Adverse Patient Experiences in Discontinuing Medication Use

World News: . []

MIAMI, May 17, 2019 (GLOBE NEWSWIRE) -- Findings of the first patient statin use survey based on a comprehensive set of patient experiences and behavioral markers were presented today at the National Lipid Association’s (NLA) 2019 Scientific Sessions.

The : was designed to collect information in the patient’s voice to serve as a foundation for increased  provider understanding of statin tolerability from the patient’s perspective in order to identify opportunities to improve adherence, medication management, clinical practices and – ultimately -- outcomes.

Additionally, patient-reported symptom severity and impact on daily life were explored to characterize patients potentially at risk of stopping treatment.

Key survey takeaways include the following:

The survey also revealed that patients are more likely to be successful with statin therapy when providers are more engaged and therapy decision-making is shared. Thus, risk-benefit discussions should be encouraged, with the ultimate goal of keeping patients on effective lipid-lowering therapies to prevent cardiovascular events.

“Because studies have shown that the risk of cardiovascular events increase with statin non-persistence or underutilization, it is crucial for clinicians to reliably identify patients who might be at risk for stopping their statin therapy,” said Terry A. Jacobson, MD, corresponding author of the STATE Survey manuscript. “The data captured by this survey provides meaningful information they can use to work hand-in-hand with patients to optimize treatment.”

The STATE survey results represented 1,500 U.S. respondents who self-reported high cholesterol, had taken a statin with the past two years, and who had experienced one or more side effects from statin use within the prior six months.

Survey results will be released in the at the time of the presentation and will be accessible online at: .

To stay up-to-date on NLA and its activities, visit or follow us on Twitter (@nationallipid), Facebook and Instagram ()

Mary Green904-309-6225407-506-2960 (cell)

More news and information about National Lipid Association

Published By:

Globe Newswire: 21:00 GMT Friday 17th May 2019

Published: .

Search for other references to "statin" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
Privacy Policy | Terms and Conditions | Contact Us